Latest news
Clarity Pharmaceuticals Announces SECuRE Trial Update on 8 GBq 67Cu-SAR-bisPSMA dose level with two additional complete responses - PR NewswirePR Newswire · Wed, 05 Aug 2026 13:02:00 GMTClarity Pharmaceuticals Reports Further Strong Efficacy and Favourable Safety from SECuRE Prostate Cancer Trial - Finance News NetworkFinance News Network · Wed, 05 Aug 2026 02:30:29 GMTClarity Pharmaceuticals (ASX:CU6) Share Price Jumps, CU6 Advances Cancer Therapy Trial Results - KalkineKalkine · Wed, 05 Aug 2026 02:08:00 GMT